SAGE THERAPEUTICS INC's ticker is and the CUSIP is 78667J958. A total of 4 filers reported holding SAGE THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,243,000 | -70.9% | 166 | -35.9% | 0.24% | -37.8% |
| Q4 2017 | $4,266,000 | +160.0% | 259 | +25.7% | 0.39% | +263.6% |
| Q2 2017 | $1,641,000 | -50.0% | 206 | -55.4% | 0.11% | -39.5% |
| Q1 2017 | $3,283,000 | +530.1% | 462 | +352.9% | 0.18% | +490.0% |
| Q4 2016 | $521,000 | -57.3% | 102 | -61.5% | 0.03% | -34.8% |
| Q3 2016 | $1,220,000 | -88.4% | 265 | -92.4% | 0.05% | -91.6% |
| Q2 2016 | $10,533,000 | – | 3,496 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 32,000 | $3,065,000 | 0.03% |
| IMC-Chicago, LLC | 14,000 | $1,341,000 | 0.00% |
| SIMPLEX TRADING, LLC | 111 | $1,063,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 1,100 | $105,000 | 0.00% |